Passage BIO, Inc. - COM NEW (PASG)

CUSIP: 702712209

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COM NEW
Total 13F shares
3,121
Share change
+3,121
Total reported value
$1,249
Price per share
$0.40
Number of holders
2
Value change
+$1,249
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 702712209?
CUSIP 702712209 identifies PASG - Passage BIO, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PASG - Passage BIO, Inc. - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lynx1 Capital Management LP
13F
Company
291%
9,256,953
$3,268,630 31 Mar 2025
13F
ORBIMED ADVISORS LLC
13F 3/4/5
Company · 10%+ Owner
191%
from 3/4/5
7,034,626
$2,483,926 31 Mar 2025
Vestal Point Capital, LP
13F
Company
192%
6,100,000
$2,153,910 31 Mar 2025
13F
New Leaf Venture Partners, L.L.C.
13F
Company
78%
2,497,922
$881,766 31 Mar 2025
13F
Erste Asset Management GmbH
13F 13D/G
Company
4.4%
from 13D/G
2,455,800
$868,700 31 Mar 2025
VANGUARD GROUP INC
13F
Company
65%
2,071,538
$731,252 31 Mar 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
47%
1,500,000
$529,650 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
44%
1,410,276
$497,969 31 Mar 2025
13F
Jill M. Quigley
3/4/5
Chief Operating Officer
mixed-class rows
399,988
mixed-class rows
$338,849 08 Dec 2021
ACADIAN ASSET MANAGEMENT LLC
13F
Company
29%
933,764
$328,000 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
23%
718,450
$253,684 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
17%
546,101
$192,872 31 Mar 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
16%
506,142
$178,719 31 Mar 2025
13F
FIDUCIARY TRUST CO
13F
Company
6.8%
215,000
$75,917 31 Mar 2025
13F
Mark S. Forman
3/4/5
CHIEF MEDICAL OFFICER
mixed-class rows
261,631
mixed-class rows
$56,272 15 Mar 2024
STATE STREET CORP
13F
Company
4.9%
156,773
$55,357 31 Mar 2025
13F
Shay Capital LLC
13F
Company
4.6%
146,717
$51,806 31 Mar 2025
13F
RBF Capital, LLC
13F
Company
4.5%
142,807
$50,425 31 Mar 2025
13F
Alexandros Fotopoulos
3/4/5
Chief Technical Officer
mixed-class rows
53,693
mixed-class rows
$48,861 15 Jun 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
4.3%
136,224
$48,101 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
3.5%
111,981
$39,540 31 Mar 2025
13F
SIMPLEX TRADING, LLC
13F
Company
2.6%
82,346
$29,000 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
2%
64,141
$22,648 31 Mar 2025
13F
Simona King
3/4/5
Chief Financial Officer
class O/S missing
23,994
$21,835 28 Jul 2023
DLK Investment Management, LLC
13F
Company
1.7%
53,000
$18,714 31 Mar 2025
13F
Monika Maria Toernsen
3/4/5
Chief Commercial Officer
mixed-class rows
18,319
mixed-class rows
$16,670 15 Sep 2022
TWO SIGMA INVESTMENTS, LP
13F
Company
1.5%
46,955
$16,580 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
1.4%
45,402
$16,031 31 Mar 2025
13F
HighTower Advisors, LLC
13F
Company
0.58%
18,346
$6,478 31 Mar 2025
13F
UBS Group AG
13F
Company
0.46%
14,486
$5,114 31 Mar 2025
13F
Richard Steven Morris
3/4/5
Chief Financial Officer
class O/S missing
5,454
$4,963 21 May 2021
Mariner, LLC
13F
Company
0.38%
11,934
$4,214 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.36%
11,596
$4,095 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.21%
6,829
$2,411 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.2%
6,316
$2,230 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0.17%
5,278
$1,864 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.13%
4,224
$1,491 31 Mar 2025
13F
MAI Capital Management
13F
Company
0.13%
4,000
$1,413 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.06%
2,000
$706 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
592
$209 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
445
$157 31 Mar 2025
13F
LRI Investments, LLC
13F
Company
0.01%
225
$79 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.01%
186
$66 31 Mar 2025
13F
HARBOUR INVESTMENTS, INC.
13F
Company
0%
60
$21 31 Mar 2025
13F
Farther Finance Advisors, LLC
13F
Company
0%
50
$19 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0%
47
$17 31 Mar 2025
13F
Edgar B. Cale
3/4/5
GC & CORPORATE SECRETARY
class O/S missing
481,386
15 Mar 2025
Thomas Richard Kassberg
3/4/5
Director
mixed-class rows
317,928
mixed-class rows
28 May 2025
Athena Countouriotis
3/4/5
Director
class O/S missing
201,857
28 May 2025
Derrell Porter
3/4/5
Director
class O/S missing
201,857
28 May 2025

Institutional Holders of Passage BIO, Inc. - COM NEW (PASG) as of Q2 2025

As of 30 Jun 2025, Passage BIO, Inc. - COM NEW (PASG) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,121 shares. The largest 2 holders included SBI Securities Co., Ltd. and LRI Investments, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q4 2025 Across Filers

Q4 2025 holders
28
Q2 2025 holders
2
Holder diff
-26
Investor Q4 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q4 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .